The genes mutated in pancreatic cancer include KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4 in combination with genomic and transcriptomic alterations facilitate cell cycle deregulation, cell survival, invasion, and metastases (2, 6, 7). This evidence concerns the gene SMAD4 and pancreatic neoplasm.